Microbiology and Clinical Medicine: A United Front Against Antimicrobial Resistance and for Patient Safety

The National Liver Institute at Menoufia University organized a series of scientific and awareness lectures delivered by a distinguished group of professors specializing in medical microbiology and immunology. The initiative aimed to establish a clear operational strategy that ensures the highest levels of patient safety and promotes medical awareness, as part of ongoing efforts to enhance the efficiency of the healthcare system and improve healthcare protocols.

Professor Dr. Rehab El Sokary, Professor of Medical Microbiology and Immunology at Zagazig University Faculty of Medicine, delivered a valuable lecture entitled: “Relearning What Is Essential for the Patient.”

In her lecture, Dr. El Sokary addressed the diagnostic policy for antibiotic use, focusing on how to accurately determine the most necessary and effective medications for each case based on laboratory findings. She also discussed the integrated therapeutic triangle, emphasizing that achieving the best clinical outcomes and improving patient conditions depends primarily on close collaboration among three key parties:

• The treating physician: responsible for diagnosing the clinical condition and monitoring the patient.
• The clinical pharmacist: responsible for dose adjustment and managing drug interactions.
• The microbiologist: responsible for laboratory support and accurate identification of the infectious microorganism.

Meanwhile, Dr. Ezza Labib, Professor of Medical Microbiology and Immunology at the Faculty of Medicine, Menoufia University, addressed the preventive and monitoring aspects of the healthcare system through a lecture focused on “Early Diagnosis and Screening for the Detection of Antibiotic-Resistant Bacteria.”

During her presentation, Dr. Labib highlighted the importance of laboratory surveillance as the first line of defense. She explained that the early detection of resistant bacterial strains plays a critical role in containing hospital-acquired infections, preventing their spread, and guiding physicians toward alternative therapeutic options before it is too late.

Commenting on these activities, Professor Dr. Osama Hegazy, Dean of the National Liver Institute, stated:

“The National Liver Institute places patient safety and the implementation of infection control standards at the forefront of its priorities. Combating antibiotic resistance is no longer a scientific luxury; it is a daily battle to protect patients’ lives, especially liver patients and immunocompromised individuals who are the most vulnerable to complications. We remain committed to providing full support and implementing these evidence-based policies throughout the institute.”

Dr. Tawfik Abdel Motaleb, Head of the Clinical Microbiology and Immunology Department at the National Liver Institute, Menoufia University, also stated:

“The role of the Clinical Microbiology Department at the institute is based on providing rapid and accurate microbiological diagnosis using the latest international technologies. Activating the ‘Antimicrobial Stewardship Team’ in collaboration with colleagues in the clinical departments and clinical pharmacy is the only way to break the cycle of bacterial resistance and ensure that every patient receives the right treatment, at the right dose, and at the right time.”